The shingles vaccine may have a dementia upside
Research suggests it could prevent and slow the progress of cognitive decline
Research suggests it could prevent and slow the progress of cognitive decline

Oxford research shows adjuvant chemicals included in vaccinations may enhance their antiviral effect

Researchers find differences according to age and education and reveal men affected as much as women

Subtle changes that contribute to cognitive decline could be flying under the radar

San Diego company’s lead drug is a potential alternative to vaccines for vulnerable patients

2025 has been a good year for immunisation science, but not in the US

Research using data from Harvard Aging Brain Study showed more active patients saw slower cognitive deterioration